Abstract
Lipid management, especially with respect to triglyceride (TG) metabolism, in patients with diabetes is not sufficient with current therapeutic agents, and new approaches for improvement are needed. Members of the angiopoietin-like protein (ANGPTL) family, specifically ANGPTL3, 4, and 8, have been reported as factors that inhibit lipoprotein lipase (LPL) activity and affect TGs. The present study investigated the association between lipid and glucose metabolism markers and the mechanism by which these proteins affect lipid metabolism. A total of 84 patients hospitalized for diabetes treatment were evaluated. Lipid and glucose metabolism markers in blood samples collected before breakfast, on the day after hospitalization, were analyzed. ANGPTL8 showed a significant positive correlation with TG values. HDL-C values displayed a significant positive correlation with ANGPTL3 but a negative correlation with ANGPTL4 and ANGPTL8. The results did not indicate a significant correlation among ANGPTL3, 4, and 8 levels. Thus, it is possible that the distribution of these proteins differs among patients. When patients were divided into groups according to the levels of ANGPTL3 and ANGPTL8, those with high levels of both ANGPTL3 and ANGPTL8 also had high levels of TG and small dense LDL-C/LDL-C (%). Multiple regression analysis indicated that low LPL, high ApoC2, high ApoC3, high ApoE, and high ANGPTL8 levels were the determinants of fasting hypertriglyceridemia. By contrast, no clear association was observed between any of the ANGPTLs and glucose metabolism markers, but ANGPTL8 levels were positively correlated with the levels of HOMA2-IR and BMI. Patients with high levels of both ANGPTL3 and ANGPTL8 had the worst lipid profiles. Among ANGPTL3, 4, and 8, ANGPTL8 is more important as a factor determining plasma TG levels. We anticipate that the results of this research will facilitate potential treatments targeting ANGPTL8 in patients with diabetes.
Highlights
Dyslipidemia with diabetes is a risk factor for cardiovascular diseases (CVD)
Our results did not indicate a significant correlation between ANGPTL3, 4, and 8 levels; a clear association was observed between the markers of lipid and glucose metabolism and angiopoietin-like protein (ANGPTL) levels
We investigated the correlation among circulating ANGPTL3, 4, and 8 levels and the association between ANGPTLs and markers of lipids, as well as glucose metabolism, in patients with diabetes
Summary
It is known that high low-density lipoprotein cholesterol (LDL-C) levels are a strong mediator of dyslipidemia, and the use of LDL-C-lowering drugs [1, 2] including statins, can decrease LDL-C levels and the risk of developing CVD. Among patients who manage LDL-C levels within the target range, those with low TG levels were shown to have a low risk of coronary artery disease [3]. This finding highlights the significance of interventions targeting TG levels and the importance of proper management of TG levels as a residual CVD risk. It is necessary to fully elucidate the mechanisms underlying lipid regulation and the actual associated condition in patients with diabetes, in order to establish relevant therapeutic strategies
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
